Litcius/Paper detail

Safety and efficacy of GLP-1 and glucagon receptor dual agonist for the treatment of type 2 diabetes and obesity: a systematic review and meta-analysis of randomized controlled trials

Bixin Deng, Tiechao Ruan, Wenting Lu, Junjie Ying, Shiping Li, Ruixi Zhou, Dezhi Mu

2024Endocrine10 citationsDOI

Topics & Concepts

MedicineType 2 diabetesGlucagon-like peptide 1 receptorDiabetes mellitusRandomized controlled trialAgonistMeta-analysisInternal medicinePharmacologyEndocrinologyReceptorDiabetes Treatment and ManagementBariatric Surgery and OutcomesPharmacology and Obesity Treatment